Wave Life Sciences Ltd. (WVE) Discusses Positive Interim Phase I Data from INLIGHT Trial of WVE-007 for Obesity - Slideshow
Corroborated by 3 sources from 3 publishers
TL;DR
Reports differ across sources; according to seekingalpha.com, wave Life Sciences: WVE-007 Data Leaves Biotech Shaken And Stirred (Downgrade) Summary - Wave Life Sciences Ltd.
Sources
1
Investing.com News
https://www.investing.com/news/stock-market-news/wave-life-sciences-stock-tumbles-30-despite-positive-trial-data-93CH-4582247
2
Bloomberg Industries
https://www.bloomberg.com/news/articles/2026-03-26/wave-plunges-after-shot-s-fat-reduction-misses-expectations
3
Investing.com News
https://www.investing.com/news/company-news/wave-life-sciences-stock-hits-52week-low-at-527-93CH-4582729
4
Investing.com News
https://www.investing.com/news/stock-market-news/wave-life-sciences-shares-tumble-on-obesity-drug-trial-data-93CH-4583123
5
Investing.com News
https://www.investing.com/news/analyst-ratings/briley-reiterates-wave-life-sciences-stock-rating-on-mixed-trial-data-93CH-4583165
6
Seeking Alpha Market News
https://seekingalpha.com/article/4886322-wave-life-sciences-wve-007-data-leaves-biotech-shaken-and-stirred-downgrade?source=feed_all_articles
7
Seeking Alpha Market News
https://seekingalpha.com/article/4886370-wave-life-sciences-ltd-wve-discusses-positive-interim-phase-i-data-from-inlight-trial-of?source=feed_all_articles